Evidence map›Paper›PMID 23403208›Full record

ReviewCurrent opinion in virology2013

Animal models for highly pathogenic emerging viruses.

David Safronetz, Thomas W Geisbert, Heinz Feldmann

Abstract readReview
In one paragraph

Review in Current opinion in virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. SARS-CoV-2 immunity in animal models.Cellular & molecular immunology · 2024
    Review
  2. Review
  3. Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  4. Review
  5. Article
  6. Review
  7. Human Organs-on-Chips for Virology.Trends in microbiology · 2020
    Review
  8. Article
  9. Evidence for SARS-CoV-2 Infection of Animal Hosts.Pathogens (Basel, Switzerland) · 2020
    Review
  10. Review
  11. Article
  12. Zika Virus Infection in Syrian Golden Hamsters and Strain 13 Guinea Pigs.The American journal of tropical medicine and hygiene · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. Evaluation of Ebola Virus Countermeasures in Guinea Pigs.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  17. Article
  18. Review
  19. Article
  20. Development of Small-Molecule Antivirals for Ebola.Medicinal research reviews · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David SafronetzLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.
Thomas W Geisbert
Heinz Feldmann

Funding

Regulatory Compliance Core - Galveston National Laboratory BSL4 OperationsUC7AI094660 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Dennis A Bente · 2011 to 2026
$208.8M
Viral Hemorrhagic Fevers: Disease Modeling and TransmissionZIAAI001089 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FELDMANN, HEINRICH · 2009 to 2025
$50.7M
Health, Safety and Training ServicesUC7AI070083 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LEMON, STANLEY M. · 2006 to 2010
$49.5M
H1N1 Influenza Disease Modeling and TransmissionZIAAI001088 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FELDMANN, HEINRICH · 2010 to 2023
$13.7M
Intramural NIH HHS Z99 AI999999Intramural NIH HHS ZIA AI001089NIAID NIH HHS UC7 AI070083NIAID NIH HHS UC7 AI094660
6 · The paper itself

Abstract

Exotic and emerging viral pathogens associated with high morbidity and mortality in humans are being identified annually with recent examples including Lujo virus in southern Africa, Severe Fever with Thrombocytopenia Syndrome virus in China and a SARS-like coronavirus in the Middle East. The sporadic nature of these infections hampers our understanding of these diseases and limits the opportunities to design appropriate medical countermeasures against them. Because of this, animal models are utilized to gain insight into the pathogenesis of disease with the overall goal of identifying potential targets for intervention and evaluating specific therapeutics and vaccines. For these reasons it is imperative that animal models of disease recapitulate the human condition as closely as possible in order to provide the best predictive data with respect to the potential efficacy in humans. In this article we review the current status of disease models for highly pathogenic and emerging viral pathogens.

Indexed as

Disease Models, AnimalAnimalsCommunicable Diseases, EmergingHumansVirus Diseases

Identifiers

PMID23403208
PMCPMC3644300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.